蒋中凯,方春锋,李芦芦,等.双侧乳腺癌质子调强与光子容积旋转调强放疗计划的剂量学评价研究[J].中华放射医学与防护杂志,2025,45(7):647-654.Jiang Zhongkai,Fang Chunfeng,Li Lulu,et al.Dosimetric evaluation of intensity modulated proton therapy and photon volumetric modulated arc therapy for bilateral breast cancer[J].Chin J Radiol Med Prot,2025,45(7):647-654
双侧乳腺癌质子调强与光子容积旋转调强放疗计划的剂量学评价研究
Dosimetric evaluation of intensity modulated proton therapy and photon volumetric modulated arc therapy for bilateral breast cancer
投稿时间:2024-07-16  
DOI:10.3760/cma.j.cn112271-20240716-00262
中文关键词:  双侧乳腺癌  容积弧形调强放疗  质子调强放疗  计划质量
英文关键词:Bilateral breast cancer  Volumetric modulated arc therapy  Intensity modulated proton therapy  Plan quality
基金项目:
作者单位E-mail
蒋中凯 河北一洲肿瘤医院物理技术部, 涿州 072750  
方春锋 河北一洲肿瘤医院物理技术部, 涿州 072750  
李芦芦 日照市人民医院放疗科, 日照 276827  
王子申 河北一洲肿瘤医院物理技术部, 涿州 072750  
李玉梅 河北一洲肿瘤医院物理技术部, 涿州 072750  
徐寿平 国家癌症中心 国家肿瘤临床医学中心 中国医学科学院北京协和医学院肿瘤医院放疗科, 北京 100021 shouping_xu@yahoo.com 
摘要点击次数: 4713
全文下载次数: 1061
中文摘要:
      目的 评价质子调强放疗(IMPT)和光子容积旋转调强放疗(VMAT)在双侧乳腺癌保乳术后患者放疗计划中的剂量学特点。方法 选取18例双侧乳腺癌患者的CT定位图像,完成靶区及危及器官的勾画,对所有病例均分别制定IMPT和VMAT放疗计划,其中IMPT计划又分别设计了基于临床靶区(CTV)理念、使用鲁棒性优化(RO)的RO-IMPT计划和基于计划靶区(PTV)理念、不使用RO的NonRO-IMPT计划,即RO-IMPT组、NonRO-IMPT组和VMAT组3组放疗计划,最后统一归一到处方剂量覆盖95%的靶区体积。分析评价靶区及各危及器官的剂量学参数并探讨两种技术的剂量学特点。结果 靶区方面,RO-IMPT组CTV靶区D1%Dmean、剂量均匀指数(HI)均低于VMAT组PTV (t=-8.96、-8.21、-8.13,P<0.05),D99%高于VMAT组PTV (t=4.96,P<0.05);NonRO-IMPT组PTV靶区D1%Dmean、HI均低于VMAT组PTV (t=-7.75、-6.25、-6.11,P<0.05)。靶区剂量适形指数(CI)高于VMAT组PTV (t=7.53,P<0.05)。危及器官方面,两组IMPT计划全肺V5~V30Dmean,心脏V5~V40Dmean,冠状动脉左前降支(LAD)D1%Dmean,脊髓D1%,正常组织(NT)Dmean,和皮肤Dmean均低于VMAT组(t=-28.47~-3.25,P<0.05)。其余评估指标间差异均无统计学意义(P>0.05)。结论 IMPT和VMAT均可满足双侧乳腺癌保乳术后放疗计划的临床要求。在危及器官保护上,IMPT技术相较于VMAT技术具有较为明显的优势。
英文摘要:
      Objective To evaluate the dosimetric characteristics of intensity-modulated proton therapy (IMPT) and photon volumetric modulated arc therapy (VMAT) in radiation therapy planning for patients with bilateral breast cancer after breast-conserving surgery. Methods On the computed tomography localization images of 18 patients with bilateral breast cancer, target volumes and organs at risk were contoured to develop both IMPT and VMAT plans for each patient. Two IMPT plans were designed based on the clinical target volume (CTV) with robust optimization (RO-IMPT) and the planning target volume (PTV) without RO (NonRO-IMPT), respectively. The RO-IMPT, NonRO-IMPT, and VMAT plans were normalized such that the prescription dose could cover 95% of the target volume. The dosimetric parameters of target volumes and organs at risk were evaluated, and the dosimetric characteristics of the two techniques were compared. Results In terms of target volumes, the RO-IMPT group showed significantly lower D1%, Dmean, and homogeneity index (HI) and a significantly higher D99% of the CTV than those of the PTV in the VMAT group (t=-8.96, -8.21, -8.13, 4.96, P<0.05). The NonRO-IMPT group showed significantly lower D1%, Dmean, and HI and a significantly higher conformity index of the PTV than those of the PTV in the VMAT group (t=-7.75, -6.25, -6.11, 7.53, P<0.05). In terms of organs at risk, the two IMPT groups showed significantly lower values than the VMAT group for the V5-V30 and Dmean of the whole lungs, V5-V40 and Dmean of the heart, D1% and Dmean of the left anterior descending coronary artery, D1% of the spinal cord, Dmean of normal tissues, and Dmean of the skin (t= -28.47 to -3.25, P<0.05). There was no significant difference in any other evaluation indices (P>0.05). Conclusions Both IMPT and VMAT can meet the clinical requirements of radiotherapy plans following breast-conserving surgery for bilateral breast cancer. IMPT has apparent advantages over VMAT in protecting organs at risk.
HTML  查看全文  查看/发表评论  下载PDF阅读器
关闭